Hilltop BioSciences

Hilltop Bio develops exosome-based cell signaling technology to reduce inflammation and provide the necessary components to restore the body's immune balance.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded September 2018
  • Employees 6
  • Incorporation Type C-corp
  • Website hilltopbio.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free